EGFR and breast carcinoma: Others have also reported pathways highlighted in our study, which are involved in pentose and glucuronate interconversions, gap junction, TGF-beta signalling, rennin-angiotensin system, B cell receptor signalling, Fc epsilon RI signalling, VEGF signalling, ErbB signalling, and focal adhesion, to be significantly associated with the breast cancer phenotype [59,60].